Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study.

Autor: Megna, Matteo1 (AUTHOR) mat24@libero.it, Ruggiero, Angelo1 (AUTHOR), Battista, Teresa1 (AUTHOR), Marano, Laura1 (AUTHOR), Cacciapuoti, Sara1 (AUTHOR), Potestio, Luca1 (AUTHOR)
Zdroj: Journal of Clinical Medicine. May2023, Vol. 12 Issue 9, p3233. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje